HTEC Among Disruptive Tech ETFs
End-of-day Nov 16, 2026 · 26 Disruptive tech ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.8% | +0.8% | +5.9% | +22.0% | +29.6% | +91.4% | −7.9% | +79.7% |
| Peer average | −2.5% | −3.3% | −4.1% | −5.6% | +4.4% | +5.7% | +72.1% | +8.3% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$25 of every $1,000 in HTEC is Grail
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GRALGrail | Healthcare | 2.48% | $247.90 | 22K | $2.8M |
| 2 | MRNAModerna | Healthcare | 2.42% | $241.54 | 11K | $2.7M |
| 3 | ISRGIntuitive Surgical | Healthcare | 2.30% | $230.20 | 5,708 | $2.6M |
| 4 | AXGNAxogen | Healthcare | 2.29% | $229.20 | 44K | $2.6M |
| 5 | CDNACaredx | Healthcare | 2.29% | $228.77 | 31K | $2.5M |
| 6 | GKOSGlaukos | Healthcare | 2.23% | $222.91 | 10K | $2.5M |
| 7 | TEMTempus AI | Healthcare | 2.23% | $222.59 | 31K | $2.5M |
| 8 | TMOThermo Fisher Scientific | Healthcare | 2.19% | $219.50 | 3,409 | $2.4M |
| 9 | ADPTAdaptive Biotechnologies | Healthcare | 2.05% | $204.82 | 76K | $2.3M |
| 10 | REGNRegeneron Pharmaceuticals | Healthcare | 2.00% | $199.60 | 2,319 | $2.2M |
| 11 | SYKStryker | Healthcare | 1.98% | $198.43 | 6,938 | $2.2M |
| 12 | PHIA.ASKoninklijke Philips | Healthcare | 1.98% | $198.02 | 73K | $2.2M |
| 13 | SHL.DESiemens Healthineers AG | Healthcare | 1.97% | $197.10 | 45K | $2.2M |
| 14 | LIVNLivanova | Healthcare | 1.97% | $196.85 | 24K | $2.2M |
| 15 | MEDPMedpace | Healthcare | 1.97% | $196.57 | 3,296 | $2.2M |
of the $48.3B in 27 Disruptive tech ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GRAL | Grail | 2.48% |
| 2 | MRNA | Moderna | 2.42% |
| 3 | ISRG | Intuitive Surgical | 2.30% |
| 4 | AXGN | Axogen | 2.29% |
| 5 | CDNA | Caredx | 2.29% |
| 6 | GKOS | Glaukos | 2.23% |
| 7 | TEM | Tempus AI | 2.23% |
| 8 | TMO | Thermo Fisher Scientific | 2.19% |
| 9 | ADPT | Adaptive Biotechnologies | 2.05% |
| 10 | REGN | Regeneron Pharmaceuticals | 2.00% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 30, 2025 | Dec 31, 2025 | $0.35 |
| Dec 28, 2021 | Dec 31, 2021 | $0.0230 |